ANI Pharmaceuticals jumps after launching generic heart drug

ANI Pharmaceuticals

08/04/2026 12:16

** Shares of drugmaker ANI Pharmaceuticals ANIP.O rise 7% to $85.09 premarket

** Co says it launched a generic version of its Monoket drug after winning U.S. FDA approval

** Drug is isosorbide mononitrate tablets in 10 mg and 20 mg doses, used to prevent chest pain linked to heart disease, co says

** Chest pain, also called angina, happens when the heart does not get enough blood and oxygen

** Launch fits ANI’s strategy of selling lower‑cost drugs in markets with limited competition, co says

** ANIP CEO says approval and launch highlight efforts to expand access to affordable medicines

** As of last close, stock up ~1% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))